RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sihuan Pharmaceutical Holdings Group Stock

Sihuan Pharmaceutical Holdings Group Debt 2024

Sihuan Pharmaceutical Holdings Group Debt

-1,880.65 CNY

Ticker

460.HK

ISIN

BMG8162K1137

WKN

A1C72G

In 2024, Sihuan Pharmaceutical Holdings Group's total debt was -1,880.65 CNY, a 34.72% change from the -1,395.97 CNY total debt recorded in the previous year.

Sihuan Pharmaceutical Holdings Group Aktienanalyse

What does Sihuan Pharmaceutical Holdings Group do?

Sihuan Pharmaceutical Holdings Group Ltd is a leading company in the Chinese pharmaceutical industry that focuses on research, development, production, and marketing of drugs, especially for the treatment of cardiovascular diseases and central nervous system diseases. The company was founded in 2001 and has become one of the largest and most successful companies in the Chinese pharmaceutical industry. It is listed on the stock exchange and has its headquarters in Beijing, China. Sihuan Pharmaceutical's business model is based on a combined strategy of researching and developing new drugs tailored to the Chinese market, as well as licensing and distributing existing drugs from both domestic and international sources. The company is divided into various business divisions to maximize its core competencies and maintain growth. The cardiovascular division is one of the most important divisions, producing and distributing cardiovascular drugs used to treat conditions such as hypertension, heart failure, arrhythmias, and other cardiovascular diseases. The central nervous system division is another important division, producing and distributing drugs to treat neurological disorders such as depression, schizophrenia, and epilepsy. In addition, the company also has products in the areas of antibiotics, antivirals, and gastroenterology. Sihuan Pharmaceutical's research and development department focuses on the discovery and development of new active substances, as well as improving existing drugs. The company collaborates with leading universities and research institutions in China and globally to develop innovative approaches in pharmacy. Sihuan Pharmaceutical has also established a strong presence in the Chinese market, building an extensive distribution network throughout China and working closely with other key players in the industry to strengthen its market position. In summary, Sihuan Pharmaceutical Holdings Group Ltd is a significant player in the Chinese pharmaceutical industry, specializing in the research, development, production, and marketing of drugs for the treatment of cardiovascular diseases and central nervous system diseases. The company is divided into multiple business divisions and has a strong presence in the Chinese market. With its strong research and development department, Sihuan Pharmaceutical is committed to improving the health and well-being of millions of people worldwide. Sihuan Pharmaceutical Holdings Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Sihuan Pharmaceutical Holdings Group's Debt Structure

Sihuan Pharmaceutical Holdings Group's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Sihuan Pharmaceutical Holdings Group's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Sihuan Pharmaceutical Holdings Group’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Sihuan Pharmaceutical Holdings Group’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Sihuan Pharmaceutical Holdings Group stock

What is the debt of Sihuan Pharmaceutical Holdings Group this year?

Sihuan Pharmaceutical Holdings Group has a debt level of -1,880.65 CNY this year.

What was the debt of Sihuan Pharmaceutical Holdings Group compared to the previous year?

The debt of Sihuan Pharmaceutical Holdings Group has increased by 34.72% compared to the previous year increased.

What are the consequences of high debt for investors in Sihuan Pharmaceutical Holdings Group?

High debt can pose a risk for investors of Sihuan Pharmaceutical Holdings Group, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Sihuan Pharmaceutical Holdings Group?

Low debt means that Sihuan Pharmaceutical Holdings Group has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Sihuan Pharmaceutical Holdings Group affect the company?

An increase in debt of Sihuan Pharmaceutical Holdings Group can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Sihuan Pharmaceutical Holdings Group affect the company?

A reduction in debt of Sihuan Pharmaceutical Holdings Group can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Sihuan Pharmaceutical Holdings Group?

Some factors that can influence the debt of Sihuan Pharmaceutical Holdings Group include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Sihuan Pharmaceutical Holdings Group so important for investors?

The debts of Sihuan Pharmaceutical Holdings Group are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Sihuan Pharmaceutical Holdings Group take to change the debt?

To change the debt, Sihuan Pharmaceutical Holdings Group can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Sihuan Pharmaceutical Holdings Group pay?

Over the past 12 months, Sihuan Pharmaceutical Holdings Group paid a dividend of 0.07 CNY . This corresponds to a dividend yield of about 11.4 %. For the coming 12 months, Sihuan Pharmaceutical Holdings Group is expected to pay a dividend of 0.05 CNY.

What is the dividend yield of Sihuan Pharmaceutical Holdings Group?

The current dividend yield of Sihuan Pharmaceutical Holdings Group is 11.4 %.

When does Sihuan Pharmaceutical Holdings Group pay dividends?

Sihuan Pharmaceutical Holdings Group pays a quarterly dividend. This is distributed in the months of October, July, October, November.

How secure is the dividend of Sihuan Pharmaceutical Holdings Group?

Sihuan Pharmaceutical Holdings Group paid dividends every year for the past 16 years.

What is the dividend of Sihuan Pharmaceutical Holdings Group?

For the upcoming 12 months, dividends amounting to 0.05 CNY are expected. This corresponds to a dividend yield of 8.19 %.

In which sector is Sihuan Pharmaceutical Holdings Group located?

Sihuan Pharmaceutical Holdings Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sihuan Pharmaceutical Holdings Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sihuan Pharmaceutical Holdings Group from 10/10/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Sihuan Pharmaceutical Holdings Group pay the last dividend?

The last dividend was paid out on 10/10/2024.

What was the dividend of Sihuan Pharmaceutical Holdings Group in the year 2023?

In the year 2023, Sihuan Pharmaceutical Holdings Group distributed 0.052 CNY as dividends.

In which currency does Sihuan Pharmaceutical Holdings Group pay out the dividend?

The dividends of Sihuan Pharmaceutical Holdings Group are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sihuan Pharmaceutical Holdings Group

Our stock analysis for Sihuan Pharmaceutical Holdings Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sihuan Pharmaceutical Holdings Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.